A proteomics- and machine learning (ML)-based precision prediction system enhances early risk stratification for diabetic ...

When a clinician prescribes a medication for a purpose for which it’s not indicated by the U.S. Food and Drug Administration (FDA), it’s referred to as off-label treatment. Doctors may recommend ...

Smoking, vaping, or using both products significantly increases the likelihood of developing prediabetes and diabetes, and the risk is even higher among Hispanic, Black, and low-income groups.

Blood glucose levels can be a reliable indicator of diabetes risk. But in some populations, it's not enough to catch the disease early. Globally, diabetes has become one of the defining health crises ...

In people with type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, responsible for regulating blood sugar and providing cells with glucose to produce ...

aNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark bDepartment of Public Health, Faculty of Health and Medical ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...

David Pogue is a six-time Emmy winner for his stories on "CBS Sunday Morning," where he's been a correspondent since 2002. Pogue hosts the CBS News podcast "Unsung Science." He's also a New York Times ...

Washington, D.C., March 24, 2026 – OrbitsIQ Global (OIQ), an innovator in AI-driven secure connectivity across terrestrial and satellite networks, today announced a major technological milestone ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...